DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 148 filers reported holding DENALI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $218,632,222 | -27.7% | 10,597,781 | +3.5% | 0.01% | -28.6% |
Q2 2023 | $302,270,428 | +29.7% | 10,242,983 | +1.2% | 0.01% | +16.7% |
Q1 2023 | $233,130,079 | -15.7% | 10,118,493 | +1.7% | 0.01% | -25.0% |
Q4 2022 | $276,628,795 | +7.3% | 9,947,098 | +18.4% | 0.01% | 0.0% |
Q3 2022 | $257,858,000 | +5.5% | 8,402,031 | +1.2% | 0.01% | +14.3% |
Q2 2022 | $244,342,000 | -6.4% | 8,302,501 | +2.3% | 0.01% | +16.7% |
Q1 2022 | $260,964,000 | -28.3% | 8,112,030 | -0.6% | 0.01% | -25.0% |
Q4 2021 | $364,004,000 | -11.7% | 8,161,530 | -0.1% | 0.01% | -20.0% |
Q3 2021 | $412,101,000 | -31.3% | 8,168,483 | +6.9% | 0.01% | -33.3% |
Q2 2021 | $599,605,000 | +28.6% | 7,644,130 | -6.4% | 0.02% | +15.4% |
Q1 2021 | $466,305,000 | -29.8% | 8,166,450 | +3.0% | 0.01% | -31.6% |
Q4 2020 | $663,803,000 | +176.4% | 7,925,057 | +18.3% | 0.02% | +137.5% |
Q3 2020 | $240,124,000 | +40.1% | 6,701,740 | -5.4% | 0.01% | +33.3% |
Q2 2020 | $171,337,000 | +41.6% | 7,085,930 | +2.6% | 0.01% | +20.0% |
Q1 2020 | $120,965,000 | +11.9% | 6,908,331 | +11.3% | 0.01% | +25.0% |
Q4 2019 | $108,135,000 | +15.8% | 6,207,542 | +1.8% | 0.00% | +33.3% |
Q3 2019 | $93,414,000 | -22.6% | 6,097,446 | +4.9% | 0.00% | -40.0% |
Q2 2019 | $120,642,000 | -21.1% | 5,811,315 | -11.7% | 0.01% | -16.7% |
Q1 2019 | $152,854,000 | +12.9% | 6,582,849 | +0.4% | 0.01% | 0.0% |
Q4 2018 | $135,423,000 | +29.0% | 6,554,883 | +35.8% | 0.01% | +50.0% |
Q3 2018 | $104,954,000 | +117.3% | 4,827,710 | +52.5% | 0.00% | +100.0% |
Q2 2018 | $48,293,000 | +116.5% | 3,166,726 | +179.5% | 0.00% | +100.0% |
Q1 2018 | $22,308,000 | +53.9% | 1,132,939 | +22.3% | 0.00% | 0.0% |
Q4 2017 | $14,494,000 | – | 926,716 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |